As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to:www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global:
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Since its establishment in 1985, PCR technology has developed rapidly and has shown extremely wide application value. Based on the basic principles of PCR, many scholars give full play to their creative thinking, research, and improve PCR technology, so that PCR technology has not only been further matured and improved, And many new application fields and methods have been derived from this basis.
The PCR technology provides a faster and simpler method than the original technology to modify DNA fragments according to special requirements. Because compared with recombinant DNA technology, PCR technology itself is relatively simple; and it can also change the base sequence of DNA more simply by chemically synthesizing oligonucleotide primers without restricting DNA fragments. Endonuclease and ligase operations; in addition, PCR technology may also be convenient for sequence modification, such as adding an “addition” sequence to the 5’end of the primer. In addition, the efficiency of modified products produced by PCR technology can reach almost 100%.
In addition, the principle of introducing DNA sequence variation through PCR primers is very useful. The simplest is that it can make one chain or the other chain or both chains of the PCR product specifically labeled with radioisotopes, biotin, or fluorescein. It can also specifically carry out site substitution, deletion, insertion, or recombination at any position in the DNA sequence. At the same time, it can accurately connect unrelated sequences and obtain heritable mutations.
In recent years, various new technologies based on PCR have been continuously updated, improved, and developed, such as in-situ PCR technology, ligase chain reaction (LCR), and nucleic acid sequence-based amplification technology (Nucleic acid sequence-based amplification). , NASBA), transcription-dependent amplification system (Transcript-based amplification system, TAS), labeled PCR technology (Labelled Primers, LP-PCR), color PCR technology (Color Complementation assay PCR, CCAPCR), reverse PCR technology (reverse PCR), asymmetric PCR technology (asymmetric PCR) and the current real-time fluorescence quantitative technology (real-time PCR), etc., are not only used in scientific research, but also social life such as animal and plant quarantine, food safety, forensic identification, etc. All aspects have increasingly greater application value.
Reverse Transcription PCR (RT-PCR) can detect less than 10 copies of specific RNA in a single cell. At present, RT-PCR is an effective method to obtain the target gene from tissues or cells, and to conduct qualitative and semi-quantitative analysis of RNA with known sequences. It is also one of the widely used PCR methods.
This technology combines RNA reverse transcription reaction with PCR reaction. Firstly, RNA is used as a template to synthesize cDNA under the action of reverse transcriptase, and then cDNA is used as a template to amplify the target gene through PCR reaction.
In Situ PCR is to amplify the target gene fragment in the cell by using the whole cell as a tiny reaction system. The PCR reaction is carried out in a single cell on a tissue section or cell smear fixed in formaldehyde solution (formalin) and wrapped in paraffin. After the PCR reaction, the specific probe is used for in-situ hybridization to detect whether the DNA or RNA to be detected exists in the tissue or cell. Because the products of conventional PCR or RT-PCR can't be directly localized in tissue cells, they can't be associated with specific tissue cell phenotypes. However, in situ hybridization has a good localization effect, but its sensitivity is not high.
In-situ PCR makes up for the shortcomings of PCR and in-situ hybridization. Combining the amplification and localization of the target gene, can not only identify the cells with the sequence but also mark the position of the target sequence in the cells. It is of great practical value to study the pathogenesis and clinical process of diseases at the molecular and cellular levels.
Conventional PCR reaction detects the product content at the end of the reaction. However, during the reaction, the product increases exponentially, and the accumulation of products after repeated cycles will affect the accurate judgment of the original template content difference. Therefore, the conventional PCR reaction can only be used as a semi-quantitative means.
Real-time PCR technology eliminates the interference of product accumulation on quantitative analysis by dynamically monitoring the number of products in the reaction process, and is also called Quantitative PCR (qPCR). The quantitative analysis of mRNA, miRNA and other non-coding RNA by PCR has been realized quickly and accurately, and it has been applied to gene diagnosis in the clinic.
Real-time PCR has the characteristics of quantification, specificity, sensitivity, and rapidity. At present, real-time fluorescence PCR has been widely used in basic scientific research, clinical diagnosis, disease research, and drug research and development. These applications will change the phenotypic cognition and phenotypic diagnosis of diseases in the past, but recognize and diagnose diseases in essence.
Real-time PCR can not only effectively detect gene mutation, rearrangement, and translocation, but also accurately detect oncogene expression. It can be used for early diagnosis, differentiation, typing, staging, treatment, and prognosis evaluation of tumors.
Real-time PCR has a good application prospect in the analysis of single nucleotide polymorphism (SNP). For example, it can be used to predict the different therapeutic responses caused by different effects of drugs in different individuals with the same disease. If drugs are used according to the characteristics of gene polymorphism, the clinical treatment will meet the individual requirements.
Real-time PCR can also be used to detect a variety of bacteria, viruses, mycoplasma, and chlamydia.
For example. The detection of the hepatitis B virus mainly depends on the indirect index of hepatitis B surface antigen (HBsAg). However, if HBsAg is positive or negative, it is difficult to judge whether the HBV in a patient is in the replication stage, how much the virus replicates, and whether the patient is infectious. The appearance of real-time PCR can accurately detect the copy number of HBV in samples and monitor the drug treatment effect and clinical status of patients in real-time.
Real-time PCR can not only characterize viruses, but also can conveniently, quickly, sensitively, and accurately quantify their DNA or RNA sequences, and dynamically observe the number of potential viruses in the course of the disease, because of its small differences between batches and within batches and good repeatability.